Immunodeficient Mice in OncologyH. H. Fiebig, D. P. Berger |
Contents
Establishment | 23 |
Human | 47 |
Dinges S Budach V Budach W Stuschke M Stüben G Essen Bamberg M | 60 |
Copyright | |
41 other sections not shown
Common terms and phrases
adenocarcinoma animals antibody anticancer drugs antigen athymic nude mice Basel Berger DP bombesin breast cancer Cancer Res carboplatin cell lines chemotherapy cisplatin clinical clonogenic assay colon colorectal compounds Contrib Oncol culture cytotoxic differentiation dose doxorubicin effect estrogen receptor evaluation experimental expression FaDu Fiebig HH fraction FRG Introduction gastrin grafts growth delay histological human tumor xenografts hyperthermia implanted injection irradiation Karger lung cancer LXFE malignant melanoma MAXF metastasis MEXF mg/kg misonidazole mm³ murine NDDO NMRI nu/nu mice nude mice nude mouse observed octreotide oncology patients phase-II preclinical prostate protein radiation radiosensitivity relative tumor volume renal resistance response SCLC sensitive showed squamous-cell carcinoma studies subcutaneously Table TCDO tested therapy thyroid tion toxicity treatment tumor cells tumor growth tumor lines tumor models tumor tissue tumor transplantation tumor types values vascular vindesine vitro vivo xenograft lines xenotransplanted